New Study Affirms Masimo Rainbow Pulse CO-Oximetry Accuracy for Noninvasive Carboxyhemoglobin and Methemoglobin Measurements

by Benzinga Staff
July 9, 2012 9:02 AM | 14 seconds read | Make a Comment

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Masimo (NASDAQ: MASI) announcedtoday a new study in Respiratory Physiology & Neurobiology shows thatnoninvasive carboxyhemoglobin (SpCO®) and methemoglobin (SpMet®) measurementswith Masimo rainbow® Pulse CO-Oximetry™ are accurate and conclude they can beused as an effective first screening test with emergency room patientssuspected of suffering carbon monoxide (CO) poisoning.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsFDAHealth CareHealth Care Equipment

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.